• xxx

CHANG, Dr David

Dr David Chang is a Reader in Surgery at University of Glasgow. His research focus on the development and implementation of novel therapeutic strategies for pancreatic cancer particularly around DNA-damage response deficiency, by utilising molecular biomarkers of therapeutic response. Dr Chang undertook his pancreatic surgical fellowship, PhD, and post-doctoral training in Australia. He was recruited to University of Glasgow in 2013, as part of an initiative to implement precision medicine in Scotland and the UK. He co-leads Precision-Panc, a Cancer Research UK precision medicine programme to deliver personalised cancer care for pancreatic cancer, and is the overall translational lead. Dr Chang is also involved in the Precision Promise, a Pancreatic Cancer Action Network (USA) precision medicine initiative. He also contributes to ICGC-ARGO, aiming to shape the future of the next generation cancer genomic projects to ultimately realise the goals and promises of precision medicine.

 

Clinically Dr Chang is a Consultant Pancreatic Surgeon at the West of Scotland Pancreatic Unit in Glasgow Royal Infirmary, a tertiary pancreatic referral centre for the West of Scotland. As a surgeon scientist, he aims to shorten the distance between the bench and the clinic to ensure meaningful and seamless translation.

UK Oncology Forum 2022

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.